Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke

Research output: Contribution to journalJournal articleResearchpeer-review

  • S W Worm
  • D A Kamara
  • P Reiss
  • E Fontas
  • S De Wit
  • W El-Sadr
  • A D'Arminio Monforte
  • M Law
  • A Phillips
  • L Ryom
  • F Dabis
  • Roy E. Weber
  • C Sabin
  • Lundgren, Jens
  • D:A:D Study Group
Concerns have arisen about possible effects of protease inhibitors (PIs) on cardiac conductivity. We found no significant association between current or recent PI exposure and sudden death or nonhemorrhagic stroke (adjusted rate ratio, 1.22; 95% confidence interval, .95-1.57), whereas cumulative exposure to PIs was associated with an increased risk (adjusted rate ratio, 1.06 per year of exposure; 95% confidence interval, 1.01-1.11).
Original languageEnglish
JournalThe Journal of Infectious Diseases
Volume205
Issue number4
Pages (from-to)535-9
Number of pages5
ISSN0022-1899
DOIs
Publication statusPublished - 15 Feb 2012

    Research areas

  • Adult, Death, Sudden, Female, HIV Infections, HIV Protease Inhibitors, Humans, Male, Middle Aged, Risk Assessment, Stroke

ID: 47789504